Iterative Health

Iterative Health is a healthcare technology and services company founded in 2017 that combines clinical trials expertise with artificial intelligence to accelerate clinical research and widen patient access to new therapeutics. Its technical work spans AI, clinical trials technology, healthcare technology and clinical research infrastructure. The company partners with providers and study sponsors to strengthen research capacity, with a stated focus on operational excellence and on closing gaps in healthcare delivery.

Its main product, the Iterative Health Site Network, comprises more than 70 clinical research sites across the United States and Europe. The network is designed to speed the path to market for novel therapies in gastroenterology (GI), hepatology, obesity and cardiology by bringing research into community care settings and increasing patient access to studies.

The company describes its mission as ensuring patients receive treatments when they need them, and it frames its approach around deep clinical trials knowledge paired with AI. Work spans the US and European markets, across the healthcare, clinical research and pharmaceutical sectors.